Targeted treatments for breast and ovarian cancer
Christie Hospital, Manchester
Description: 1-day course providing an overview of the cellular and genetic makeup of breast and ovarian cancer, along with information on targeted treatments in use and in development for these cancers. The focus of the course is on treatments such as HER2-inhibitors, PARP inhibitors and angiogenesis inhibitors, rather than on hormone treatments.
Level: Advanced (Designed for doctors, research nurses and other experienced oncology staff working in breast and ovarian cancer)
To book contact: email@example.com
View the programme
Full details, and cost information, can be found on the Christie Website